SCHEMBL13499564

SCHEMBL13499564

Cc1cccc(C)c1/C=C1\SC(=S)NC1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAT1 P18440 7/20 0.70
CA2 P00918 1/20 0.59
EPHX1 P07099 1/20 0.59
ALDH1A1 P00352 3/20 0.56
GAA P10253 2/20 0.56
MEN1 O00255 2/20 0.56
LMNA P02545 2/20 0.56
MAPT P10636 2/20 0.56
KMT2A Q03164 2/20 0.56
NPC1 O15118 1/20 0.56
POLB P06746 1/20 0.56
PIM1 P11309 3/20 0.55
PTP4A3 O75365 1/20 0.55
CISD1 Q9NZ45 2/20 0.55
PDE4B Q07343 1/20 0.53
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
RECQL P46063 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MAOA P21397 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1249066 0.83 TTR (0.69) MEN1KMT2ANPC1PIM1CISD1
SCHEMBL1249071 0.83 TTR (0.69) MEN1KMT2ANPC1PIM1CISD1
SCHEMBL9573277 0.83 NAT1 (1.00) NAT1CA2EPHX1ALDH1A1GAA
SCHEMBL9573270 0.83 NAT1 (1.00) NAT1CA2EPHX1ALDH1A1GAA
SCHEMBL11315685 0.81 NAT1 (0.70) NAT1CA2EPHX1ALDH1A1MEN1
SCHEMBL11315688 0.81 NAT1 (0.70) NAT1CA2EPHX1ALDH1A1MEN1
SCHEMBL32672283 0.81 NAT1 (0.74) NAT1CA2EPHX1ALDH1A1GAA
SCHEMBL14661291 0.81 PIM1 (0.70) NAT1CA2EPHX1PIM1PTP4A3
SCHEMBL13499576 0.81 PTP4A3 (0.72) NAT1CA2EPHX1PIM1PTP4A3
SCHEMBL18102954 0.81 NAT1 (0.70) NAT1CA2EPHX1PIM1PTP4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206169-B2 Method for producing benzo[b]thiophene compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-12-08 US disclosed
US-20140187782-A1 METHOD FOR PRODUCING BENZO[B]THIOPHENE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-07-03 US disclosed
US-8431376-B2 Bacterial replication systems and methods THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2013-04-30 US disclosed
US-20100028862-A1 BACTERIAL REPLICATION SYSTEMS AND METHODS Replidyne,Inc. (US) 2010-02-04 US disclosed
WO-2006071255-A9 BACTERIAL REPLICATION SYSTEMS AND METHODS REPLIDYNE INC (US) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140187782-A1 METHOD FOR PRODUCING BENZO[B]THIOPHENE COMPOUND H1-4, H1-0, RB1 NAT1 806/4885CA2 2200/4885EPHX1 1985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.